Researchers from Wellcome Sanger Institute and University of Oxford found that descendants of one multi-drug resistant malaria strain are replacing local parasite populations
Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed ...